BCL7A anticorps (C-Term)

N° du produit ABIN2854648

Détail du produit anti-BCL7A anticorps

Antigène: BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

Épitope: C-Term

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCL7A est non-conjugé

Application: Western Blotting (WB), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Attributs du produit: Rabbit Polyclonal antibody to BCL7A (B-cell CLL/lymphoma 7A)
BCL7A antibody [C2C3], C-term

Purification: Purified by antigen-affinity chromatography.

Immunogène: Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human BCL7A. The exact sequence is proprietary.

Isotype: IgG

Information d'application

Indications d'application: Suggested dilution Reference ICC/IF 1:100-1:1000* IHC (Formalin-fixed paraffin-embedded sections) 1:100-1:1000* Western blot 1:500-1:3000* Not tested in other applications. *Optimal dilutions/concentrations should be determined by the researcher.Suggested dilutionReferenceICC/IF1:100-1:1000* IHC (Formalin-fixed paraffin-embedded sections)1:100-1:1000* Western blot1:500-1:3000*

Commentaires:

Positive Control: HeLaS3 , Neuro2A , GL261

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1XPBS, 20 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.

Agent conservateur: Thimerosal (Merthiolate)

Précaution d'utilisation: This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Détails sur BCL7A

Antigène: BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

Autre désignation: BCL7A (BCL7A Produits)

Synonymes: anticorps BCL7, anticorps cb585, anticorps id:ibd1097, anticorps sb:cb585, anticorps wu:fk02d01, anticorps zgc:92023, anticorps 4432415N06Rik, anticorps AI448316, anticorps bcl7a, anticorps MGC89576, anticorps BCL7A, anticorps BCL tumor suppressor 7A, anticorps B-cell CLL/lymphoma 7A, anticorps B cell CLL/lymphoma 7A, anticorps B-cell CLL/lymphoma 7A L homeolog, anticorps BCL7A, anticorps bcl7a, anticorps Bcl7a, anticorps bcl7a.L

Sujet: This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.

Poids moléculaire: 23 kDa

ID gène: 605